- Open Access
Magnetic resonance-guided focused ultrasound treatment of facet joint pain: summary of preclinical phase
- Sagi Harnof†1Email author,
- Zion Zibly†1, 2,
- Lilach Shay1,
- Osnat Dogadkin1,
- Arik Hanannel3,
- Yael Inbar4,
- Itay Goor-Aryeh5 and
- Israel Caspi6
© Harnof et al.; licensee BioMed Central Ltd. 2014
- Received: 13 June 2013
- Accepted: 8 October 2013
- Published: 28 February 2014
A phantom experiment, two thermocouple experiments, three in vivo pig experiments, and a simulated treatment on a healthy human volunteer were conducted to test the feasibility, safety, and efficacy of magnetic resonance-guided focused ultrasound (MRgFUS) for treating facet joint pain.
The goal of the current study was to develop a novel method for accurate and safe noninvasive facet joint ablation using MRgFUS.
Summary of background data
Facet joints are a common source of chronic back pain. Direct facet joint interventions include medial branch nerve ablation and intra-articular injections, which are widely used, but limited in the short and long term. MRgFUS is a breakthrough technology that enables accurate delivery of high-intensity focused ultrasound energy to create a localized temperature rise for tissue ablation, using MR guidance for treatment planning and real-time feedback.
We validated the feasibility, safety, and efficacy of MRgFUS for facet joint ablation using the ExAblate 2000® System (InSightec Ltd., Tirat Carmel, Israel) and confirmed the system's ability to ablate the edge of the facet joint and all terminal nerves innervating the joint. A phantom experiment, two thermocouple experiments, three in vivo pig experiments, and a simulated treatment on a healthy human volunteer were conducted.
The experiments showed that targeting the facet joint with energies of 150–450 J provides controlled and accurate heating at the facet joint edge without penetration to the vertebral body, spinal canal, or root foramina. Treating with reduced diameter of the acoustic beam is recommended since a narrower beam improves access to the targeted areas.
MRgFUS can safely and effectively target and ablate the facet joint. These results are highly significant, given that this is the first study to demonstrate the potential of MRgFUS to treat facet joint pain.
- Chronic back pain
- Facet joints
- Pain palliation
Lumbar zygapophysial joint arthropathy is a challenging condition affecting up to 15% of patients with chronic low back pain. The onset of lumbar facet joint pain is usually insidious with predisposing factors including spondylolisthesis, degenerative disc pathology, and old age . Facet joint ablation to reduce low back pain is a medically accepted and reimbursed procedure, which is gaining more and more popularity recently. The evidence for pain relief after radiofrequency (RF) neurotomy of the cervical and lumbar medial branch nerves is moderate for short- and long-term pain relief, and indeterminate for thoracic facet neurotomy [2, 3]. Noninvasive thermal ablation using magnetic resonance-guided focused ultrasound (MRgFUS) has been found to be clinically effective for the palliation of pain caused by bone metastases [4–6] and is currently being evaluated in a pivotal clinical study.
MRgFUS is a well-established technology for the noninvasive thermoablation of various benign and malignant soft tissue and bone tumors. The ExAblate 2000® system (InSightec Ltd., Tirat Carmel, Israel) delivers treatment using focused ultrasound (FUS) in conjunction with real-time magnetic resonance imaging (MRI) guidance to selectively ablate targeted tissue by inducing localized heating . The uniqueness of MRgFUS is based on a technology that facilitates real-time MRI monitoring and control, thereby supplying a high-quality anatomical image of the patient's internal organs and a real-time temperature map for monitoring the thermal rise in the targeted region [7–9]. Accordingly, this allows for treatment adjustments based on ongoing monitoring of the therapeutic effect on the tissue and also assures maximum efficiency and safety. Such real-time feedback does not exist for other localized treatment modalities. The current study evaluated the feasibility, safety, and efficacy of MRgFUS for facet joint pain palliation using a series of in vitro and animal studies, as well as a simulated treatment on a healthy human volunteer. Specifically, this study aimed to build the foundation of data required for initiating phase 1 clinical research.
The rationale behind performing several types of experiments was to evaluate the potential of MRgFUS for facet joint ablation using various tools, thereby compensating for the advantages and disadvantages of each. The goal of the phantom experiment was to measure the relative thermal rise in the entire three-dimensional volume of tissue surrounding the vertebra using MR thermometry. The goal of the thermocouple experiments was to provide a more accurate and absolute thermal reading focused on the areas, which if damaged, could cause neurological deficits. The goal of the animal experiments was to examine real-time thermometry in a living organism as well as posttreatment clinical imaging and histopathology evaluation of treatment outcome. The goal of the simulated treatment on a healthy human volunteer was to project our animal study results on a human anatomical model.
In order to evaluate the feasibility, safety, and efficacy of MRgFUS for facet joint pain palliation, a phantom experiment, two thermocouple experiments, three in vivo pig experiments, and a simulated treatment on a healthy human volunteer were conducted. All experiments were conducted using the ExAblate 2000® System, with imaging done by the system pelvic coil. The experiments took place at Sheba Medical Center (Tel Hashomer, Israel). The research team constituted collaboration between Dr. Sagi Harnof and Dr. Zion Zibly (neurosurgeons), Dr. Yael Inbar (radiologist), Dr. Israel Caspi and Dr. Shay Tenenbaum (orthopedic spine surgeons), and Dr. Itay Goor-Aryeh and Dr. Adrian Greenfeld (anesthesiologists and pain specialists). All animal experiments were performed under local animal ethics committee approvals. The imaging session on a human volunteer was performed with approval from the local human ethics committee (Sheba Medical Center, Israel) and after the subject gave his consent. Based on current results and accumulated data from bone metastases ablation [4, 5], we estimated that sonications of 150–450 J with appropriate angling would provide the desired therapeutic effect for accurate ablation of the facet joint within a safe margin.
Magnetic resonance-guided focused ultrasound technology
MRgFUS treatment commences with a planning phase, whereby the physician co-registers and analyzes the MR and CT images, defines the targeted area for treatment, and prescribes a detailed treatment plan. After the targeted location is defined and confirmed, the parameters are adjusted using the ExAblate software. The treatment is based on multiple sonication spots that accumulate to cover the targeted volume. In combination with real-time guidance, the ExAblate system maneuvers the robotic arm of the ultrasound probe to deliver the acoustic energy to the targeted region. Since the facet joint is a major contributor of pain in patients with lumbar zygapophysial joint arthropathy, ablating the source of pain has the potential to produce lasting pain relief. Since this process also destroys local nerve endings, potential pain palliation is very rapid. During delivery of the FUS energy to each treatment spot, thermal images provide real-time feedback of the treatment location and measure thermal rise, allowing the physician to adjust the treatment parameters for the desired result. Finally, posttreatment contrast imaging is used to confirm the treatment outcome, based on nonperfused volume (NPV), which represents successful ablation.
Phantom experiment (MR thermometry)
Sonication parameters used in the facet joint phantom experiment
Temperature at the focal point (°C)
Average temperature in the vicinity of the intervertebral foramen (°C)
Phantom experiment (thermocouple measurements)
In vivo animal experiments
MRgFUS procedures were performed on the facet joints of three young pigs (4–6 months old). Six to eight facet joints in each pig were treated with energies of 150, 300, and 450 J. Thoracic and lumbar spine vertebrae were treated from different orientations with appropriate access. Following the MRgFUS procedure, the second and third pigs were sent to the Animal Research Institute (Lahav, Israel) for veterinary care and follow-up. The first pig remained at the Sheba Animal Laboratory and was imaged and sacrificed after 1 day of follow-up. The second pig went through the same procedure after 1 week of follow-up, and the third pig after 6 weeks.
Each facet joint was treated with 2–4 sonications for maximal coverage. Focus was placed on the facet joint surface, and each sonication orientation was adjusted to avoid heating of the spinous process in the near field and nerve roots and spinal canal heating in the far field (Figure 5). In the treatment of the third pig, a transducer apodization technique was used in half of the facet joints that were treated, which allowed shutting off the outer elements of the transducer (blue ring in Figure 6) and sonicating with a narrower beam pass zone (radius = 80%). Planned power was applied using only enabled elements. A narrower beam allows better optimization of the transducer orientation (against the sensitive locations in the beam pass zone) since it minimizes the beam pass zone intersection with the vertebral spinous process.
Histological examination using hematoxylin and eosin stains was performed for all nerve roots located anterior to the treatment area (a total of eight roots). In addition, for each studied animal, hematoxylin and eosin stains were performed for the entire relevant segment of the spinal cord and dura along with two segments below and above the lesion level.
Treatment simulation on human spine
Phantom experiment (MR thermometry)
The phantom experiment showed that targeting the facet joints using the ExAblate 2000® system can produce controlled heating in the facet joint. Spinal nerve roots showed a temperature rise of 6°C in the extreme-case scenario, represented by treatment with 1,200 J, which is four to eight times more than the expected nominal energy (the temperature rise is linearly correlated to the energy). A summary of the measurement results is displayed in Table 1. Although a nominal treatment of the facet joint should be performed using a frequency of f = 1.35 MHz in order to minimize the risk of acoustic energy penetration into the vertebra (the higher the frequency, the higher the absorption at the bone surface), in this experiment, several of the nominal and all extreme-case scenario sonications were performed with a frequency of f = 1 MHz, for which the penetration of ultrasound into the bone is higher. As recorded in Table 1, there is a linear and consistent elevation of temperature consistent with the increase of energy. The temperature elevation at the focal point did not show this linear and consistent elevation, which is believed to be due to the fact that the focus on the bone surface creates high energy density levels on the facet joint (the smaller the area and the higher the energy levels are), and minor changes like spot location or an angle can create a variety of results.
Phantom experiment (thermocouple measurements)
The results of the thermocouple experiment confirm the ability to induce a controlled temperature rise at the targeted facet joint and nearby tissue with minimal heating of the nontargeted area. In the extreme-case scenario, which included the worst possible orientation of the acoustic beam, a temperature rise of 5.2°C was measured in the far field at the nerve root location, which is still an acceptable situation. These results correlate well with the results of the MR thermometry phantom experiment.
Summary of the average temperature rise and its range
Average temperature rise measured (°C)
In vivo animal experiments
A neurological follow-up was performed following the experiment, which included a series of tests for walking, light running, abrupt standing up, and eating and drinking habits. According to the veterinary evaluation at Lahav, the last two pigs treated had a normal neurological evaluation result and were eating and drinking normally. In the gross pathology evaluation of the first two pigs (the third still in follow-up), there was no evidence of thermal damage to the spinal column or spinal nerve root.
Based on the final histological evaluation of all specimens, there is no evidence of nerve damage or adverse changes associated with the treatment. No histological changes were seen on the nerve roots or spinal cord; specifically, no ablative changes were seen. However, at the edge of the targeted facet joint, we were able to identify ablative changes as expected.
Treatment simulation on human spine
We demonstrated the ability to target the facet joint and that the avoidance of critical structures by the ultrasound beam is well within the system's capabilities. The main results of this demo are shown in Figure 9, which shows the system planning spots in green and that the targeted facet joint is device accessible.
Facet joint pain is a common and challenging condition. Current existing treatment options include RF ablation and spinal calm stabilization with hardware. Both these techniques are invasive yet effective with some drawback. The evidence supporting pain relief and control following RF ablation is diverse in the literature, with pain relief success rate of 55%–85% at 1 year [1, 2]. Systematic reviews have established moderate and limited evidence for radiofrequency neurotomy of thoracic medial branches [2, 3]. Manchikanti et al. reviewed 13 studies and concluded that the evidence for therapeutic benefit is limited for RF neurotomy . In addition, the efficacy of both short- and long-term pain relief is moderate and limited . Stabilization of the effected facet by means of hardware and fusion carries limitation with pain relief and surgical complications, and there is consensus on its value. Cohen et al. reported that there is no evidence to support surgical fusion for lumbar facetal joint pain other than that resulting from traumatic dislocation . Gibson et al. in their review on surgery for degenerative lumbar spondylosis reported that eight trials on instrumented fusion produced higher fusion rates with no improvement in clinical outcomes and higher complication rates. Moreover, it was difficult to assess fusion in the presence of metal work in these trials .
A noninvasive, real-time, controlled, safe approach to the treatment of facet joint pain is warranted, for which MRgFUS provides a viable alternative. Utilizing the FUS technique enables tailoring of precise ablation to cover the entire facet joint surface in a single short session, thereby limiting the ablation to the desired location and enhancing the safety profile of the procedure. Furthermore, multiple facet joints can be treated in a single session. The MR guidance provides accurate anatomical visualization for targeting of the facet joint, real-time monitoring, and control of treatment using closed-loop thermal feedback and immediate posttreatment evaluation of outcome using contrast-enhanced imaging.
To enhance the safety of our method, we chose not to target the proximal region of the median nerve but rather to cover the entire facet surface where nerve endings terminate to innervate the joint. By using this approach, we maintained the ablation focus dorsal to the median branch and therefore increased the safety profile of the procedure. Treating the facet joints with energies of 150, 300, and 450 J resulted in a controlled heating at the facet joint edge with no significant penetration to the vertebral body, the spinal canal, or the root foramina. Based on the results and accumulated data from bone metastases ablation [4–6], we estimate that sonications of 150–450 J would provide the desired therapeutic effect with a high safety profile. To ascertain the safety margin, extreme-case scenarios were tested, in some cases using energies of up to 1,200 J, with lower frequencies than would be used during a clinical procedure, (1 MHz instead of 1.35 MHz) with smaller and less calcified vertebrae and in a media with no perfusion or cerebrospinal fluid. Even when considering all of the above, the outcome was still well within the desired safety parameters. Based on the animal studies and human simulation, our results indicate that treating while using apodization is recommended since a narrower beam allows for better optimization of the transducer orientation against the sensitive locations in the beam pass zone. Even in extreme-case scenarios that were tested with extreme energies of up to 1,200 J and the worst orientation, our results showed a maximal temperature rise of 6°C at the spinal nerve roots, which is considered safe (see Table 1). This diminutive increase in temperature following ultrasonic ablation would likely not cause any permanent nerve tissue damage. As shown in other studies, nervous tissue (such as the cranial nerve) present a threshold of 50°C to 60°C to cause permanent damage . In addition, studies done on peripheral nerves (sciatic nerve) showed that permanent damage and conduction block will happen only at a temperature above 50°C .
The strength of the current study is that it combines several in vitro and in vivo studies to test the safety and efficacy of MRgFUS for facet joint ablation. Each experiment compliments the other, thereby compensating for the advantages and disadvantages of each.
The phantom experiment, with the combination of thermal imaging, enables performing volumetric imaging, although the temperature measured is only relative using MRI. The thermocouple experiments generated a more precise and absolute temperature reading but only in limited locations and with decreased spatial certainty due to the artifacts in MRI caused by the thermocouples. The first experiment used thermocouples immersed in water, simulating the nerve root immersed in cerebrospinal fluid. In the second experiment, thermocouples were glued to the bone, again simulating an extreme-case scenario where the nerve is touching the bone. The in vivo pig experiment generates an online volumetric thermal reading in an in vivo environment, with the same perfusion and type of tissue as in a human subject. However, it involves technical and financial difficulties and has the shortcoming of different vertebral shapes and calcifications (since pigs were young and vertebrae were smaller and less calcified). Nevertheless, this could be an additional safety consideration since it is expected that far field heating in humans would be even lower than anything recorded in the pigs. Human vertebrae are expected to be larger and more calcified and are therefore better at blocking energy. Another safety consideration will be the challenge of planning and targeting the HIFU in humans, where we expect to observe degenerative changes or irregular bony surfaces. This obstacle will be overcome with high-resolution MRI and planning. The benefits of the pig experiments include correlation of the thermal dose with the postprocedural imaging results (T2-weighted and contrast-enhanced MR imaging). It also allows clinical outcome evaluation over the follow-up period for pigs 2 and 3, based on the veterinary exam, as well as gross pathology evaluation of targeted and nontargeted sensitive tissue following the dissection of pigs 1 and 2. The imaging simulation of the healthy human volunteer is advantageous since it shows the human anatomy of the spine. Nevertheless, this is still a healthy volunteer with no back pain due to facet joint problems. As such, human volunteers suffering from facet joint pain should be tested in future clinical trials.
We believe that similar to RF, MRgFUS will be found to be an effective treatment with the advantage of being completely noninvasive and possibly with higher accuracy that may impact clinical outcomes. MRgFUS provides long-term relief using a single noninvasive treatment, eliminating the risk of bleeding and infection, thereby shortening recovery time and reducing morbidity. Since MRgFUS is a radiation-free therapy, there are no long-term toxicity or accumulated dosage effects. As such, repeated treatments can be performed in the same patient as many times as required. MRgFUS has a high safety and efficacy profile and is accurate with supporting data. Other advantages of MRgFUS include its ability to localize the target tissue and monitor accuracy, thermal effects, and treatment outcome in real time, without trajectory constraints, thereby optimizing target coverage.
MRgFUS is already an established treatment for other clinical applications such as uterine fibroid therapy (under FDA and CE approval and the approval of the Ministries of Health in Israel, Japan, and Korea, as well as other regulatory bodies around the world), with an excellent record of safety and efficacy [14–16]. MRgFUS is also under clinical investigation as a treatment for tumors of the breast [17–20], prostate , liver [22, 23], and brain [24–27]. Given its exemplary safety and efficacy profile, the future of MRgFUS for the treatment of facet joint pain is a bright one. The results of the current study indicate that MRgFUS offers a potentially novel alternative treatment for facet joint pain palliation. Given its noninvasiveness, accuracy, safety, efficacy, and the ability to be performed on an outpatient basis, it may offer a revolutionary solution to patients suffering from facet joint pain. Although further preclinical and clinical studies are required, the current results are promising and provide a solid basis for further exploration.
In conclusion, our results cumulatively show that MRgFUS can safely and effectively target and ablate the facet joint. This is the first study to demonstrate the potential of MRgFUS to treat facet joint pain and may represent a breakthrough in the treatment of chronic lower back pain due to lumbar zygapophysial joint arthropathy.
- Cohen SP, Raja SN: Pathogenesis, diagnosis, and treatment of lumbar zygapophysial (facet) joint pain. Anesthesiology. 2007, 106: 591-614. 10.1097/00000542-200703000-00024.View ArticlePubMedGoogle Scholar
- Boswell MV, Colson JD, Sehgal N, Dunbar EE, Epter R: A systematic review of therapeutic facet joint interventions in chronic spinal pain. Pain Physician. 2007, 10: 229-53.PubMedGoogle Scholar
- Nath S, Nath CA, Pettersson K: Percutaneous lumbar zygapophysial (facet) joint neurotomy using radiofrequency current, in the management of chronic low back pain: a randomized double-blind trial. Spine (Phila Pa 1976). 2008, 33: 1291-7. 10.1097/BRS.0b013e31817329f0.View ArticleGoogle Scholar
- Liberman B, Gianfelice D, Inbar Y, Beck A, Rabin T, Shabshin N, Chander G, Hengst S, Pfeffer R, Chechick A, Hanannel A, Dogadkin O, Catane R: Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study. Ann Surg Oncol. 2009, 16: 140-6. 10.1245/s10434-008-0011-2.View ArticlePubMedGoogle Scholar
- Gianfelice D, Gupta C, Kucharczyk W, Bret P, Havill D, Clemons M: Palliative treatment of painful bone metastases with MR imaging-guided focused ultrasound. Radiology. 2008, 249: 355-63. 10.1148/radiol.2491071523.View ArticlePubMedGoogle Scholar
- Lee JE, Yoon SW, Kim KA, Lee JT, Shay L, Lee KS: Successful use of magnetic resonance-guided focused ultrasound surgery for long-term pain palliation in a patient suffering from metastatic bone tumor. J Korean Soc Radiol. 2011, 65: 133-8.Google Scholar
- Jolesz FA: MRI-guided focused ultrasound surgery. Annu Rev Med. 2009, 60: 417-30. 10.1146/annurev.med.60.041707.170303.PubMed CentralView ArticlePubMedGoogle Scholar
- Dick EA, Gedroyc WM: ExAblate magnetic resonance-guided focused ultrasound system in multiple body applications. Expert Rev Med Devices. 2010, 7: 589-97. 10.1586/erd.10.38.View ArticlePubMedGoogle Scholar
- Valero P, Gomez-Gonzalez E, Sabino A, Valero M, Suarez-Ramos J: Magnetic resonance-guided focused ultrasound surgery in the treatment of oncology patients – fundamentals and review of early clinical applications. Eur Oncol. 2010, 6: 76-9.Google Scholar
- Manchikanti KN, Atluti S, Singh V, Geffert S, Sehgal N, Falco E: An update of therapeutic thoracic facet joint interventions. Pain Physician. 2012, 15 (4): E463-81.PubMedGoogle Scholar
- Gibson JN, Waddell G: Surgery for degenerative lumbar spondylosis. Cochrane Database Syst Rev. 2005, 18: 1352-Google Scholar
- Harnof S, Zibly Z, Cohen Z, Shaw A, Schlaff C, Kassel NF: Cranial nerve threshold for thermal injury induced by MRI-guided high-intensity focused ultrasound (MRgHIFU): preliminary results on an optic nerve model. IEEE. 2013, 60: 702-5.Google Scholar
- Luo GQ, Liu XJ, Peng KR, Liu Y, Yang HJ, Yang ZM: Effect of radiofrequency of different temperatures and durations on motor conduction velocity of rat sciatic nerve. Nan Fang Yi Ke Da Xue Xue Bao. 2010, 30: 579-83.PubMedGoogle Scholar
- Chapman A, Ter Haar G: Thermal ablation of uterine fibroids using MR-guided focused ultrasound–a truly non-invasive treatment modality. Eur Radiol. 2007, 17: 2505-11. 10.1007/s00330-007-0644-8.View ArticlePubMedGoogle Scholar
- Kim HS, Baik JH, Pham LD, Jacobs MA: MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol. 2011, 18: 970-6. 10.1016/j.acra.2011.03.008.PubMed CentralView ArticlePubMedGoogle Scholar
- Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM: Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007, 110: 279-87. 10.1097/01.AOG.0000275283.39475.f6.View ArticlePubMedGoogle Scholar
- Brenin DR: Focused ultrasound ablation for the treatment of breast cancer. Ann Surg Oncol. 2011, 18: 3088-94. 10.1245/s10434-011-2011-x.View ArticlePubMedGoogle Scholar
- Furusawa H, Yasuda Y, Shidooka J, Nakahara H, Hirabara E, Inomata M, Machida E, Maeda Y, Komaki K: Magnetic resonance image guided focused ultrasound surgery of early breast cancer: efficacy and safety in excisionless study. Cancer Res. 2009, 69 (24 Suppl): 4126-View ArticleGoogle Scholar
- Furusawa H, Namba K, Nakahara H, Tanaka C, Yasuda Y, Hirabara E, Imahariyama M, Komaki K: The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer. 2007, 14: 55-8. 10.2325/jbcs.14.55.View ArticlePubMedGoogle Scholar
- Gianfelice D, Khiat A, Amara M, Belblidia A, Boulanger Y: MR imaging-guided focused ultrasound surgery of breast cancer: correlation of dynamic contrast-enhanced MRI with histopathologic findings. Breast Cancer Res Treat. 2003, 82: 93-101. 10.1023/B:BREA.0000003956.11376.5b.View ArticlePubMedGoogle Scholar
- Pauly KB, Diederich CJ, Rieke V, Bouley D, Chen J, Nau WH, Ross AB, Kinsey AM, Sommer G: Magnetic resonance-guided high-intensity ultrasound ablation of the prostate. Top Magn Reson Imaging. 2006, 17: 195-207. 10.1097/RMR.0b013e31803774dd.View ArticlePubMedGoogle Scholar
- Fischer K, Gedroyc W, Jolesz FA: Focused ultrasound as a local therapy for liver cancer. Cancer J. 2010, 16: 118-24. 10.1097/PPO.0b013e3181db7c32.View ArticlePubMedGoogle Scholar
- Kopelman D, Inbar Y, Hanannel A, Dank G, Freundlich D, Perel A, Castel D, Greenfeld A, Salomon T, Sareli M, Valeanu A, Papa M: Magnetic resonance-guided focused ultrasound surgery (MRgFUS). four ablation treatments of a single canine hepatocellular adenoma. HPB (Oxford). 2006, 8: 292-8. 10.1080/13651820500465212.View ArticleGoogle Scholar
- McDannold N, Clement GT, Black P, Jolesz F, Hynynen K: Transcranial magnetic resonance imaging- guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery. 2010, 66: 323-32. 10.1227/01.NEU.0000360379.95800.2F.PubMed CentralView ArticlePubMedGoogle Scholar
- Colen RR, Jolesz FA: Future potential of MRI-guided focused ultrasound brain surgery. Neuroimaging Clin N Am. 2010, 20: 355-66. 10.1016/j.nic.2010.05.003.View ArticlePubMedGoogle Scholar
- Martin E, Jeanmonod D, Morel A, Zadicario E, Werner B: High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann Neurol. 2009, 66: 858-61. 10.1002/ana.21801.View ArticlePubMedGoogle Scholar
- Cohen ZR, Zaubermann J, Harnof S, Mardor Y, Nass D, Zadicario E, Hananel A, Castel D, Faibel M, Ram Z: Magnetic resonance imaging-guided focused ultrasound for thermal ablation in the brain: a feasibility study in a swine model. Neurosurgery. 2007, 60: 593-600.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.